Iraq - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Iraq Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases decreased by 8% year on year. In 2019, the country was ranked number 126 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 129 Cases. Iraq is overtaken by Mali, which was number 125 with 130 Cases and is followed by Bolivia at 126 Cases. India topped the ranking with 66,255 Cases in 2019, a growth of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 129.00 |
| 2018 | 126.00 |
| 2017 | 100.00 |
| 2016 | 187.00 |
| 2015 | 93.00 |
How does Iraq rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 125 |
#125
Mali
|
130 | 2019 | +5.7 % | +26.6 % | View data | |
| 126 |
#126
Iraq
|
129 | 2019 | +2.4 % | -8.0 % | View data | |
| 127 |
#127
Bolivia
|
126 | 2019 | +14.6 % | +2.8 % | View data | |